Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant Glioma
This study has been terminated.
( Poor accrual )
Study NCT00045721 Information provided by Pediatric Brain Tumor Consortium
First Received: September 6, 2002 Last Updated: October 15, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Central Nervous System Neoplasms
Glioma
Nervous System Neoplasms
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Nervous System Diseases
Neuroectodermal Tumors
Interventions listed in this trial
O6-benzylguanine
adjuvant therapy
conventional surgery
neoadjuvant therapy
Additional drug interventions recognized in this trial
Carmustine
O(6)-benzylguanine
More general drug interventions related to this trial
Alkylating Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)
Back to top of Main Content
